For every CEO, here's key reasons why to engage with PharmaKonsult
- Preparing for First Commercial Launch
- Building a High-Performance Commercial Organization
- Evaluating Commercial Leadership
- Preparing for Investors and the Board
- Commercial Due Diligence
- Rare Disease Launch Planning
Why Joseph McCoy
- 30+ years commercial leadership
- Commercialization plans completed for three start-up companies
- Multiple #1 launches
- Neuroscience expertise
- Rare disease expertise
- Ten-time Pinnacle Club leader
- Former Pfizer, Lundbeck, SK Life Science, Xeris
- Former U.S. Navy Officer
Practice Areas
Five areas of commercial leadership
PharmaKonsult partners with biotechnology CEOs and boards across the commercial decisions that define company value—from culture and leadership through launch, rare disease, and therapeutic specialization.
Commercial Culture & Leadership
Scientific innovation discovers new possibilities. Leadership and culture determine whether those possibilities reach patients.
We help biotechnology organizations build cultures of trust, accountability, and commercial discipline—before and through launch.
Learn More
Commercial Leadership & Organizational Performance
High-performing commercial organizations are designed intentionally—not assembled at the last minute.
We advise on leadership structure, role clarity, talent, and performance systems from pre-commercial through growth.
Learn More
Launch Excellence
Commercial success is shaped years before FDA approval—not in the final months before launch.
We help integrate commercialization into development: market reality, access, physician confidence, and leadership decisions.
Learn More
Neuroscience Rare Disease
Neuroscience rare disease launches face dispersed patients, long diagnostic journeys, and concentrated Centers of Excellence.
Specialized commercial guidance for assets where diagnosis, access, and stakeholder dynamics are uniquely complex.
Learn More
Endocrinology Rare Disease
Endocrinology rare disease markets demand precise stakeholder mapping, access planning, and specialty commercial execution.
Strategy and launch approaches built for these therapeutic realities—and for the patients and physicians who depend on them.
Learn More